Zevra Therapeutics, Inc. ZVRA
10.26 USD +0.16 (+1.58%)
At closeNov 3, 2026, 7:23 PM EST
10.68 +0.42 +4.09%
After hours · Nov 3, 7:23 PM ET
10.04 Day range 10.42
8.10 52-week range 14.75
- YTD
- +14.51%
- 1 year
- +0.49%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 106.47M | 23.61M | 27.46M | 10.16M | 28.65M | |
| 89.99M | 16.20M | 25.29M | 9.94M | 26.59M | |
| -62.94M | -87.00M | -49.60M | -42.56M | 7.73M | |
| 83.23M | -105.51M | -46.05M | -26.77M | -8.55M | |
| 1.35 | -2.28 | -1.30 | -0.78 | -2.11 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 62.41M | 33.78M | 43.05M | 65.47M | 112.35M | |
| 284.73M | 178.13M | 172.33M | 115.34M | 132.94M | |
| 130.07M | 138.46M | 110.46M | 40.22M | 5.82M | |
| 63.21M | 60.30M | 43.77M | 14.12M | 1.59M | |
| 154.66M | 39.67M | 61.86M | 75.12M | 127.12M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -1.60M | -69.67M | -33.53M | -18.72M | 10.44M | |
| 18.13M | -22.16M | -17.39M | -36.72M | -15.52M | |
| 12.06M | 82.11M | 28.46M | 8.35M | 113.11M | |
| -387.00K | 0 | -296.00K | -93.00K | -102.00K | |
| 28.62M | -9.26M | -22.42M | -46.88M | 108.02M |